Today is June 15, 2024.
All times in Eastern Daylight Time.
-
Virpax® Pharmaceuticals to Present at 2024 BIO International Convention
BERWYN, Pa.--(BUSINESS WIRE)--Virpax to Present at 2024 BIO International Convention more »
-
AST SpaceMobile and Verizon Announce Plans to Target 100 Percent Geographical Coverage of the Continental United States from Space on Premium 850 MHz Cellular Spectrum
MIDLAND, Texas & BASKING RIDGE, N.J.--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), and Verizon (NYSE, NASDAQ: VZ) today announced a strategic partnership with a commit... more »
-
Redwire Expands Investment in Artificial Intelligence Strategy to Enhance its Space Domain Awareness Capabilities
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that it is expanding investment in the ... more »
-
Lincoln Electric to Present at the Stifel 2024 Cross Sector Insight Conference
CLEVELAND--(BUSINESS WIRE)--Lincoln Electric Holdings, Inc. (Nasdaq: LECO) today announced that Steven B. Hedlund, President and Chief Executive Officer, will speak at the Stifel 2024 Cross Sector ... more »
-
PAR Technology Elevates Table Service Experience with Brink POS 2024 Spring Release
NEW HARTFORD, N.Y.--(BUSINESS WIRE)--ParTech, Inc. (PAR), a global restaurant technology company providing unified commerce solutions for enterprise restaurants, today announces its PAR Brink POS® ... more »
-
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment of Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has accepted for priority review ... more »
-
Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, announced initial data from t... more »
-
CareDx to Participate in Upcoming Investor Conferences
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinic... more »
-
Chewy Announces First Quarter 2024 Financial Results
PLANTATION, Fla.--(BUSINESS WIRE)--Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, has released its financial results for the first quarter of fis... more »
-
Blackstone Real Estate Sells Turtle Bay Resort
NEW YORK--(BUSINESS WIRE)--Blackstone Real Estate today announced that it has reached an agreement to sell Turtle Bay Resort for $725 million. Blackstone purchased the hotel in 2018 for $332 millio... more »
-
D-Wave Quantum Featured in The Wall Street Journal
PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software, and services and the world’s first commercial supp... more »
-
Meketa Capital Launches Website
BOSTON--(BUSINESS WIRE)--Meketa Capital, LLC ("Meketa Capital"), the recently launched subsidiary of Meketa Investment Group, Inc. (“Meketa Investment Group”) focused on delivering private markets ... more »
-
ConocoPhillips to acquire Marathon Oil Corporation in all-stock transaction; provides shareholder distribution update
HOUSTON--(BUSINESS WIRE)--ConocoPhillips to acquire Marathon Oil Corporation in all-stock transaction; provides shareholder distribution update. more »
-
bluebird bio Appoints O. James Sterling as Chief Financial Officer
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced that O. James Sterling, has been appointed chief financial officer (CFO), effective June 10, 2024. Mr. Sterling... more »
-
Rocket Pharmaceuticals Receives Orphan Medicinal Product Designation from the European Commission for RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare dis... more »
-
Origin Materials and Bachmann Group to Mass Produce PET Caps and Closures
WEST SACRAMENTO, Calif. & HOCHDORF, Switzerland--(BUSINESS WIRE)--Origin Materials (“Origin”) (NASDAQ: ORGN, ORGNW), the world’s leading carbon negative materials company with a mission to enable t... more »
-
Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoim... more »
-
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
BOSTON & PRINCETON, N.J.--(BUSINESS WIRE)--Foundation Medicine and PMV Pharma partner to develop FoundationOne®CDx as a companion diagnostic for PMV Pharma’s rezatapopt. more »
-
Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart Diseases
RAMAT-GAN, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncolog... more »
-
Element 1 Corp. and Ballard Power Systems Collaborate on Revolutionary Hydrogen Power Solutions
BEND, Ore.--(BUSINESS WIRE)--Element 1 Corp, a pioneer in on-demand hydrogen generation technology, and Ballard Power Systems (NASDAQ: BLDP; TSX: BLDP), have joined forces to accelerate the adoptio... more »
-
Covalon Announces Profitable Second Quarter Fiscal 2024 Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 se... more »
-
ReposiTrak Adds 25 New Produce Companies to the Queue for the Rapidly Expanding Food Traceability Network
SALT LAKE CITY--(BUSINESS WIRE)--ReposiTrak queues new produce companies for its network, ensuring FSMA 204 compliance with a cloud-based solution, no extra hardware needed more »
-
Trinity Lutheran School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All Students
CONKLIN, Mich. & ST. LOUIS--(BUSINESS WIRE)--Trinity Lutheran School today announced an exciting partnership with Varsity Tutors for Schools, a Nerdy (NYSE: NRDY) company and the leading platform f... more »
-
Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company developing innovative therapies for the treatment of immune-mediated a... more »
-
Viking Reports First Quarter 2024 Financial Results
LOS ANGELES--(BUSINESS WIRE)--Viking Holdings Ltd (the “Company” or “Viking”) (NYSE: VIK) today reported financial results for the first quarter ended March 31, 2024. Key Highlights Adjusted Gross ... more »
|
|